Alternative Dosing Strategy of Ruxolitinib in Patients With Myelofibrosis

Clinical trial NCT01445769 · COMPLETED

Trial details

NCT number: NCT01445769
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Myelofibrosis Post-Polycythemia Vera Myelofibrosis Post-Essential Thrombocythemia Myelofibrosis

Start date: 2011-09-01
Primary completion: 2013-03-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.